Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sodium-dependent serotonin transporter (Homo sapiens (Human)) | BDBM215794 (US9302981, 54b) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 22.8 | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
REVIVA PHARMACEUTICALS, Inc. US Patent | Assay Description The radioligand binding assays were carried out at four different test concentrations and the test concentrations were 1 nM, 10 nM, 0.1 μM, and ... | US Patent US9302981 (2016) BindingDB Entry DOI: 10.7270/Q2WS8S3H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Sodium-dependent dopamine transporter (Homo sapiens (Human)) | BDBM215794 (US9302981, 54b) | NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 45.2 | n/a | 56.9 | n/a | n/a | n/a | n/a | n/a | n/a |
REVIVA PHARMACEUTICALS, Inc. US Patent | Assay Description The radioligand binding assays were carried out at four different test concentrations and the test concentrations were 1 nM, 10 nM, 0.1 μM, and ... | US Patent US9302981 (2016) BindingDB Entry DOI: 10.7270/Q2WS8S3H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Sodium-dependent serotonin transporter (Homo sapiens (Human)) | BDBM215795 (US9302981, 54d) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 67.6 | n/a | 415 | n/a | n/a | n/a | n/a | n/a | n/a |
REVIVA PHARMACEUTICALS, Inc. US Patent | Assay Description The radioligand binding assays were carried out at four different test concentrations and the test concentrations were 1 nM, 10 nM, 0.1 μM, and ... | US Patent US9302981 (2016) BindingDB Entry DOI: 10.7270/Q2WS8S3H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Sodium-dependent noradrenaline transporter (Homo sapiens (Human)) | BDBM215794 (US9302981, 54b) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 120 | n/a | 121 | n/a | n/a | n/a | n/a | n/a | n/a |
REVIVA PHARMACEUTICALS, Inc. US Patent | Assay Description The radioligand binding assays were carried out at four different test concentrations and the test concentrations were 1 nM, 10 nM, 0.1 μM, and ... | US Patent US9302981 (2016) BindingDB Entry DOI: 10.7270/Q2WS8S3H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Sodium-dependent noradrenaline transporter (Homo sapiens (Human)) | BDBM215795 (US9302981, 54d) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 180 | n/a | 182 | n/a | n/a | n/a | n/a | n/a | n/a |
REVIVA PHARMACEUTICALS, Inc. US Patent | Assay Description The radioligand binding assays were carried out at four different test concentrations and the test concentrations were 1 nM, 10 nM, 0.1 μM, and ... | US Patent US9302981 (2016) BindingDB Entry DOI: 10.7270/Q2WS8S3H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Sodium-dependent dopamine transporter (Homo sapiens (Human)) | BDBM215795 (US9302981, 54d) | NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 294 | n/a | 370 | n/a | n/a | n/a | n/a | n/a | n/a |
REVIVA PHARMACEUTICALS, Inc. US Patent | Assay Description The radioligand binding assays were carried out at four different test concentrations and the test concentrations were 1 nM, 10 nM, 0.1 μM, and ... | US Patent US9302981 (2016) BindingDB Entry DOI: 10.7270/Q2WS8S3H | |||||||||||
More data for this Ligand-Target Pair |